Quantcast

Latest Retinoids Stories

2010-08-10 06:00:00

Findings refute earlier health warning issued by the Environmental Working Group SCHAUMBURG, Ill., Aug. 10 /PRNewswire-USNewswire/ -- Despite previous concerns about the cancer-causing potential of sunscreens containing retinyl palmitate (vitamin A), an independent analysis published online in the Journal of the American Academy of Dermatology (JAAD) determined that there is no evidence that the inclusion of retinyl palmitate in sunscreens can cause cancer in humans. "Earlier this...

2010-07-06 09:19:00

MELVILLE, N.Y., July 6 /PRNewswire/ -- E. Fougera & Co., a leading specialty pharmaceutical manufacturer, announced it has received first generic approval from the FDA for Adapalene Cream 0.1% (Rx). Fougera's Adapalene Cream 0.1% is rated AB, generically equivalent to Differin® by Galderma Pharmaceuticals. According to industry data, U.S. sales of the brand named product in 2009 exceeded $55 million. This approval also marks the fourth product approval that the FDA...

6f3d0fb956d626e45b6b50790936f0f21
2010-06-14 12:30:00

A senator asked the U.S. Food and Drug Administration on Sunday to reveal findings on a possible link between a chemical found in most sunscreens and skin cancer. The FDA has been reviewing data from several studies on a potential link between retinal palmitate (RP), a common sunscreen additive, and cases of skin cancer.  However, Senator Charles Schumer said no rulings or guidelines have been issued yet. "With the recent reports suggesting a possible link between skin cancer and a...

2010-06-04 08:15:00

FORT WORTH, Texas, June 4 /PRNewswire/ -- With such intense competition and pressure on today's teens to get into a good college, line up a strong summer internship and land the perfect summer job, many parents feel that summer is an ideal time for their teens to get ahead. However, the stress of a busy school year followed by a similarly hectic summer could cause teens to suffer from stress-related medical conditions such as acne.(i) June marks National Acne Awareness Month across the...

2010-05-18 12:30:40

Individuals treated for acne, psoriasis or another skin condition with vitamin A analogues (retinoids) do not appear to be at increased risk of fracture, according to a report in the May issue of Archives of Dermatology, one of the JAMA/Archives journals. "High doses of vitamin A as dietary intake or supplements have been associated with adverse skeletal effects," the authors write as background information in the article. Very high doses of vitamin A analogues"”compounds similar to...

2010-04-13 08:30:00

FORT WORTH, Texas, April 13 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the availability of a new nozzle for Clobex® (clobetasol propionate 0.05%) Spray, a super-potent topical steroid indicated to treat moderate to severe plaque psoriasis in patients 18 years and older. The new packaging for Clobex® Spray, which will be on pharmacy shelves nationwide beginning later this month, features a more targeted nozzle delivery system to help...

2010-04-12 09:55:00

SCHAUMBURG, Ill., April 12 /PRNewswire-USNewswire/ -- While everyone knows that getting an adequate daily dose of vitamins and minerals is important in maintaining one's overall health, many question whether or not the vitamins touted in skin care products work in reducing the signs of sun-damaged skin. Now, a new study reviews the currently published scientific literature to determine what evidence exists to support the use of vitamins in skin care products to slow or reverse the effects...

2010-03-22 08:00:00

FORT WORTH, Texas, March 22 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the U.S. Food and Drug Administration (FDA) approval of Differin® (adapalene) Lotion, 0.1%, the first-ever lotion formulation of the well-tolerated retinoid adapalene, for the treatment of acne. Differin Lotion, 0.1% will be available by prescription in April 2010. Differin Lotion, 0.1% is formulated for tolerable efficacy, spreads easily and is available in a convenient, easy-to-use...

2010-03-01 07:00:00

ALISO VIEJO, Calif., March 1 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX), today announced that it has entered into an agreement with Spear Pharmaceuticals, Inc. for rights to commercialize Refissa®, a prescription-based topical tretinoin cream used to diminish fine wrinkles and fade irregular pigmentation due to sun damage. Valeant will pay Spear a $12 million upfront payment and the two companies will share net profits. Valeant will book...

2010-02-23 05:30:00

HAYWARD, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related